Capstone Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $560K | Sell |
1,908
-202
| -10% | -$59.3K | 0.02% | 844 |
|
|
2017
Q1 | $743K | Sell |
2,110
-308
| -13% | -$108K | 0.02% | 693 |
|
|
2016
Q4 | $445K | Sell |
2,418
-791
| -25% | -$146K | 0.01% | 1019 |
|
|
2016
Q3 | $827K | Sell |
3,209
-36
| -1% | -$9.28K | 0.02% | 666 |
|
|
2016
Q2 | $693K | Buy |
3,245
+282
| +10% | +$60.2K | 0.02% | 736 |
|
|
2016
Q1 | $611K | Sell |
2,963
-138
| -4% | -$28.5K | 0.02% | 793 |
|
|
2015
Q4 | $784K | Sell |
3,101
-238
| -7% | -$60.2K | 0.02% | 682 |
|
|
2015
Q3 | $549K | Buy |
+3,339
| New | +$549K | 0.02% | 849 |
|
|
2013
Q4 | – | Sell |
-874
| Closed | -$137K | – | 1935 |
|
|
2013
Q3 | $137K | Sell |
874
-6
| -0.7% | -$941 | ﹤0.01% | 1917 |
|
|
2013
Q2 | $152K | Buy |
+880
| New | +$152K | ﹤0.01% | 1843 |
|